HC Wainwright Brokers Reduce Earnings Estimates for MNPR
Monopar Therapeutics Inc. (NASDAQ:MNPR - Free Report) - Equities researchers at HC Wainwright lowered their Q1 2026 EPS estimates for Monopar Therapeutics in a report issued on Monday, March 30th. HC Wainwright analyst A. Maldonado now forecasts that the company will earn ($0.77) per share for the q

What's Your Reaction?











